DAXXIFY 100 U/1.2mL
botulinum toxin type A · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Revance Therapeutics, Inc.
No Recall History
Plain English
DAXXIFY is a injection, powder, lyophilized, for solution containing botulinum toxin type a at 100 U/1.2mL, taken intramuscular. Manufactured by Revance Therapeutics, Inc..
Key Facts
- Brand Name
- DAXXIFY
- Generic Name
- botulinum toxin type A
- NDC Code (Product)
72960-112- Manufacturer
- Revance Therapeutics, Inc.
- Strength
- 100 U/1.2mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA761127
- Drug Class
- Acetylcholine Release Inhibitor [EPC]; Neuromuscular Blocker [EPC]
- Marketing Start
- 09/20/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is DAXXIFY used for?
DAXXIFY contains botulinum toxin type A. It is a injection, powder, lyophilized, for solution taken intramuscular. Consult your doctor for specific uses.
Is DAXXIFY a controlled substance?
DAXXIFY is not classified as a controlled substance by the DEA.
What is the generic name for DAXXIFY?
The generic name for DAXXIFY is botulinum toxin type A. There are 3 other brand versions of botulinum toxin type A.
What is the NDC code for DAXXIFY 100 U/1.2mL?
The NDC (National Drug Code) for DAXXIFY 100 U/1.2mL is 72960-112, listed by Revance Therapeutics, Inc..